These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6060284)

  • 21. Increased platelet aggregation in diabetes mellitus.
    Kwaan HC; Colwell JA; Cruz S; Suwanwela N; Dobbie JG
    J Lab Clin Med; 1972 Aug; 80(2):236-46. PubMed ID: 5044780
    [No Abstract]   [Full Text] [Related]  

  • 22. Proteinuria and blood glucose levels in a population with diabetic retinopathy.
    Jerneld B; Algvere P
    Am J Ophthalmol; 1987 Sep; 104(3):283-9. PubMed ID: 3631186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteinuric renal disease in type 2 diabetes-is remission of proteinuria associated with improved mortality and morbidity?
    Tan J; Jaung R; Gamble G; Cundy T
    Diabetes Res Clin Pract; 2014 Jan; 103(1):63-70. PubMed ID: 24380605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between nocturnal urinary 6-sulfatoxymelatonin, obstructive sleep apnea severity and glycemic control in type 2 diabetes.
    Reutrakul S; Siwasaranond N; Nimitphong H; Saetung S; Chirakalwasan N; Chailurkit LO; Srijaruskul K; Ongphiphadhanakul B; Thakkinstian A
    Chronobiol Int; 2017; 34(3):382-392. PubMed ID: 28128991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excess renal insufficiency among type 2 diabetic patients with dip-stick positive proteinuria in a tertiary hospital.
    Balogun WO; Abbiyesuku FM
    Afr J Med Med Sci; 2011 Dec; 40(4):399-403. PubMed ID: 22783692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteinuria, renal impairment, metabolic control, and blood pressure in type 2 diabetes mellitus. A 14-year follow-up report on 195 patients.
    Ravid M; Savin H; Lang R; Jutrin I; Shoshana L; Lishner M
    Arch Intern Med; 1992 Jun; 152(6):1225-9. PubMed ID: 1599351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin converting enzyme inhibitors versus calcium antagonists in the treatment of diabetic hypertensive patients.
    Ferder L; Daccordi H; Martello M; Panzalis M; Inserra F
    Hypertension; 1992 Feb; 19(2 Suppl):II237-42. PubMed ID: 1735586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is endogenous creatinine clearance still a reliable index of glomerular filtration rate in diabetic patients?
    Friedman R; De Azevedo MJ; Gross JL
    Braz J Med Biol Res; 1988; 21(5):941-4. PubMed ID: 3150296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma type IV collagen and fibronectin concentrations in diabetic patients with microangiopathy.
    Lee IK; Park KY; Oh HK; Park RW; Jo JS
    J Korean Med Sci; 1994 Aug; 9(4):341-6. PubMed ID: 7848583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
    Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of irisin concentrations with the presence of diabetic nephropathy and retinopathy.
    Hu W; Wang R; Li J; Zhang J; Wang W
    Ann Clin Biochem; 2016 Jan; 53(Pt 1):67-74. PubMed ID: 25814621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Early detection of diabetic nephropathy: serum beta 2-microglobulin].
    Goebel FD; Schmeidl T; Füessl HS; Vogel S
    Klin Wochenschr; 1983 Dec; 61(23):1209-15. PubMed ID: 6361371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
    Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary protein/creatinine ratio before and during pregnancy in women with diabetes mellitus.
    Combs CA; Wheeler BC; Kitzmiller JL
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 1):920-3. PubMed ID: 1951554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoreactive growth hormone in plasma and urine in long term insulin treated diabetics with clinical diabetic nephropathy.
    Hanssen KF; Svendsen PA; Evrin PE
    Acta Endocrinol (Copenh); 1974 Jan; 75(1):75-86. PubMed ID: 4406483
    [No Abstract]   [Full Text] [Related]  

  • 36. ["Diabetic" proliferative retinopathy and nodular glomerulosclerosis without diabetes mellitus].
    Biesenbach G; Hommer K; Stadler G; Kramar R; Syré G; Zazgornik J
    Dtsch Med Wochenschr; 1988 Dec; 113(50):1968-71. PubMed ID: 3197624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Association of albuminuria with adipokines, inflammation and insulin resistance in non-diabetic subjects].
    Vasilescu R; Ionescu-Tîrgovişte C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1174-82. PubMed ID: 22276466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased prevalence of proliferative retinopathy and cardiovascular autonomic dysfunction in IDDM patients with proteinuria.
    Zander E; Seidlein I; Herfurth S; Heinke P; Chlup R; Badendick K; Strese J; Zander G; Schulz B
    Exp Clin Endocrinol; 1992; 99(2):102-7. PubMed ID: 1639116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal findings and glomerular pathology in diabetic subjects.
    Wirta O; Helin H; Mustonen J; Kuittinen E; Savela T; Pasternack A
    Nephron; 2000 Mar; 84(3):236-42. PubMed ID: 10720894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetic complications and their relationships to risk factors in a Japanese population.
    Ishihara M; Yukimura Y; Yamada T; Ohto K; Yoshizawa K
    Diabetes Care; 1984; 7(6):533-8. PubMed ID: 6510179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.